blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2414362

EP2414362 - PYRIMIDINE SUBSTITUTED PURINE COMPOUNDS AS KINASE (S) INHIBITORS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  17.04.2015
Database last updated on 25.09.2024
Most recent event   Tooltip22.06.2018Lapse of the patent in a contracting state
New state(s): MK
published on 25.07.2018  [2018/30]
Applicant(s)For all designated states
Verastem, Inc.
215 First Street, Suite 440
Cambridge, MA 02142 / US
[2012/41]
Former [2012/06]For all designated states
S*BIO Pte Ltd
1 Science Park Road 05-09 The Capricorn Singapore Science Park II
Singapore 117528 / SG
Inventor(s)01 / CHEN, DiZhong
Block 212
11-126
Chua Chu Kang Central
Singapore 680 212 / SG
02 / WILLIAMS, Meredith
1E Pine Grove
01-18
Singapore 594001 / SG
 [2014/18]
Former [2012/06]01 / CHEN, DiZhong
Block 212
11-126
Chua Chu Kang Central
Singapore 680 212 / SG
02 / WILLIAMS, Meredith
1 Pine Grove
04-66
Singapore 591 301 / SG
Representative(s)Schwahn, Hartmut, et al
Gleiss Große Schrell und Partner mbB
Patentanwälte Rechtsanwälte
Leitzstraße 45
70469 Stuttgart / DE
[2014/24]
Former [2012/06]Schwahn, Hartmut, et al
Gleiss Grosse Schrell & Partner Patentanwälte Rechtsanwälte Leitzstraße 45
70469 Stuttgart / DE
Application number, filing date09788615.403.04.2009
WO2009SG00124
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010114484
Date:07.10.2010
Language:EN
[2010/40]
Type: A1 Application with search report 
No.:EP2414362
Date:08.02.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 07.10.2010 takes the place of the publication of the European patent application.
[2012/06]
Type: B1 Patent specification 
No.:EP2414362
Date:11.06.2014
Language:EN
[2014/24]
Search report(s)International search report - published on:EP07.10.2010
ClassificationIPC:C07D473/32, A61K31/52, A61P35/00
[2012/06]
CPC:
C07D473/32 (EP,US); A61K31/5377 (EP,US); A61P1/00 (EP);
A61P1/04 (EP); A61P1/16 (EP); A61P11/00 (EP);
A61P11/02 (EP); A61P11/06 (EP); A61P13/08 (EP);
A61P13/12 (EP); A61P15/00 (EP); A61P17/00 (EP);
A61P17/04 (EP); A61P17/06 (EP); A61P17/14 (EP);
A61P19/02 (EP); A61P21/04 (EP); A61P25/00 (EP);
A61P27/02 (EP); A61P29/00 (EP); A61P3/10 (EP);
A61P35/00 (EP); A61P35/02 (EP); A61P35/04 (EP);
A61P37/00 (EP); A61P37/02 (EP); A61P37/06 (EP);
A61P37/08 (EP); A61P43/00 (EP); A61P5/14 (EP);
A61P7/00 (EP); A61P7/04 (EP); A61P7/06 (EP);
A61P9/00 (EP); A61P9/10 (EP); C07D487/04 (EP,US);
C12N9/12 (EP,US); C12N9/1205 (EP,US); C12Y207/01137 (EP,US);
C12Y207/11001 (EP,US); Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2012/06]
Extension statesALNot yet paid
BANot yet paid
RSNot yet paid
TitleGerman:PYRIMIDINSUBSTITUIERTE PURINVERBINDUNGEN ALS KINASE-(S)-INHIBITOREN[2012/06]
English:PYRIMIDINE SUBSTITUTED PURINE COMPOUNDS AS KINASE (S) INHIBITORS[2012/06]
French:COMPOSÉS DE PURINE SUBSTITUÉE PAR PYRIMIDINE EN TANT QU'INHIBITEURS D'UNE OU PLUSIEURS KINASES[2012/06]
Entry into regional phase03.11.2011National basic fee paid 
03.11.2011Designation fee(s) paid 
03.11.2011Examination fee paid 
Examination procedure02.11.2011Amendment by applicant (claims and/or description)
03.11.2011Examination requested  [2012/06]
17.01.2013Despatch of a communication from the examining division (Time limit: M06)
21.06.2013Reply to a communication from the examining division
03.07.2013Despatch of a communication from the examining division (Time limit: M02)
10.08.2013Reply to a communication from the examining division
03.12.2013Communication of intention to grant the patent
24.03.2014Fee for grant paid
24.03.2014Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  17.01.2013
Opposition(s)12.03.2015No opposition filed within time limit [2015/21]
Fees paidRenewal fee
03.11.2011Renewal fee patent year 03
29.03.2012Renewal fee patent year 04
29.04.2013Renewal fee patent year 05
30.04.2014Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU03.04.2009
AT11.06.2014
BE11.06.2014
BG11.06.2014
CY11.06.2014
CZ11.06.2014
EE11.06.2014
HR11.06.2014
LT11.06.2014
LV11.06.2014
MC11.06.2014
MK11.06.2014
MT11.06.2014
PL11.06.2014
RO11.06.2014
SI11.06.2014
SK11.06.2014
TR11.06.2014
NO11.09.2014
GR12.09.2014
IS11.10.2014
PT13.10.2014
[2018/30]
Former [2017/39]HU03.04.2009
AT11.06.2014
BE11.06.2014
BG11.06.2014
CY11.06.2014
CZ11.06.2014
EE11.06.2014
HR11.06.2014
LT11.06.2014
LV11.06.2014
MC11.06.2014
MT11.06.2014
PL11.06.2014
RO11.06.2014
SI11.06.2014
SK11.06.2014
TR11.06.2014
NO11.09.2014
GR12.09.2014
IS11.10.2014
PT13.10.2014
Former [2017/03]AT11.06.2014
BE11.06.2014
CZ11.06.2014
EE11.06.2014
HR11.06.2014
LT11.06.2014
LV11.06.2014
MC11.06.2014
MT11.06.2014
PL11.06.2014
RO11.06.2014
SI11.06.2014
SK11.06.2014
NO11.09.2014
GR12.09.2014
IS11.10.2014
PT13.10.2014
Former [2016/01]AT11.06.2014
BE11.06.2014
CZ11.06.2014
EE11.06.2014
HR11.06.2014
LT11.06.2014
LV11.06.2014
MC11.06.2014
PL11.06.2014
RO11.06.2014
SI11.06.2014
SK11.06.2014
NO11.09.2014
GR12.09.2014
IS11.10.2014
PT13.10.2014
Former [2015/36]AT11.06.2014
BE11.06.2014
CZ11.06.2014
EE11.06.2014
HR11.06.2014
LT11.06.2014
LV11.06.2014
PL11.06.2014
RO11.06.2014
SI11.06.2014
SK11.06.2014
NO11.09.2014
GR12.09.2014
IS11.10.2014
PT13.10.2014
Former [2015/30]AT11.06.2014
BE11.06.2014
CZ11.06.2014
EE11.06.2014
HR11.06.2014
LT11.06.2014
LV11.06.2014
PL11.06.2014
RO11.06.2014
SK11.06.2014
NO11.09.2014
GR12.09.2014
IS11.10.2014
PT13.10.2014
Former [2015/12]AT11.06.2014
CZ11.06.2014
EE11.06.2014
HR11.06.2014
LT11.06.2014
LV11.06.2014
PL11.06.2014
RO11.06.2014
SK11.06.2014
NO11.09.2014
GR12.09.2014
IS11.10.2014
PT13.10.2014
Former [2015/11]CZ11.06.2014
EE11.06.2014
HR11.06.2014
LT11.06.2014
LV11.06.2014
PL11.06.2014
RO11.06.2014
SK11.06.2014
NO11.09.2014
GR12.09.2014
PT13.10.2014
Former [2015/10]CZ11.06.2014
EE11.06.2014
HR11.06.2014
LT11.06.2014
LV11.06.2014
SK11.06.2014
NO11.09.2014
GR12.09.2014
Former [2014/50]HR11.06.2014
LT11.06.2014
LV11.06.2014
NO11.09.2014
GR12.09.2014
Former [2014/49]LT11.06.2014
NO11.09.2014
Former [2014/48]LT11.06.2014
Cited inInternational search[A]EP1277738  (YAMANOUCHI PHARMA CO LTD [JP], et al) [A] 1-46 * claims 1,8-12 *;
 [A]WO2004048365  (CHIRON CORP [US], et al) [A] 1-46 * claims 1,9,23,26-36 *
by applicantWO2008SG00379
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.